Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-305

5 FDA label images from Dr. Reddy's Laboratories Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 43598-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Azacitidine depicted as a molecular diagram showing its ring structures and functional groups.*
FDA Label Image

Graph (Graph)

Graph (Graph)
A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months from randomization) for two groups labeled AZA and CCR. It shows survival probabilities plotted with AZA group in black having higher survival compared to CCR group in grey. The chart includes number at risk tables for both groups at various time points and states statistical results including Log-Rank p=0.0001, hazard ratio 0.58 with 95% confidence interval 0.43-0.77, and death counts for each group.*
FDA Label Image

Vialfto11 (Vialfto11)

Vialfto11 (Vialfto11)
Label for Azacitidine For Injection 100 mg/vial, a lyophilized powder for injection by subcutaneous and intravenous use. The label notes it as a cytotoxic agent requiring dilution and is supplied as one single-dose vial. Distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ, with storage instructions and safety warnings.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Packaging label for Azacitidine For Injection 100 mg/vial, a lyophilized powder for solution by Dr. Reddy's Laboratories Inc. The label states it is for subcutaneous and intravenous use, is cytotoxic, must be diluted, and contains one single-dose vial. Storage instructions at 20-25°C and safety warnings are included.*
FDA Label Image

Cartonfto11 (Cartonfto11)

Cartonfto11 (Cartonfto11)
Packaging label for Azacitidine For Injection 100 mg/vial, a lyophilized powder for intravenous and subcutaneous use by Dr. Reddy's Laboratories Inc. The label indicates it is a cytotoxic agent, must be diluted, and supplied as a single-dose vial. Storage instructions and distributor information are also present along with barcodes and NDC 43598-305-62.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.